Varsha Gandhi

21PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 07, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations.

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Oct 28, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

Shady I Tantawy, Burcu Aslan, Ganiraju Manyam

|May 13, 2025
Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers.

Mohd Mughees, Moises Tacam, Alex W Tan

|Apr 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

Varsha Gandhi, Shady Tantawy, Burcu Aslan

|Feb 14, 2025
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice.

Natalia Timofeeva, Nitin Jain, Varsha Gandhi

Pageof 4

Frequent Collaborators

8 joint publications

William Wierda

5 joint publications

Natalia Timofeeva

4 joint publications

Keyur Patel

3 joint publications

Prithviraj Bose